Skip to main content

Table 2 Adverse outcomes after non-cardiac surgeries associated with CHA2DS2-VASc score in patients with atrial fibrillation

From: Septicemia and mortality after noncardiac surgery associated with CHA2DS2-VASc score: a retrospective cohort study based on a real-world database

Postoperative outcomes

Scores

N

Risk of outcome

Events

Incidence,%

OR (95% CI)†

Pneumonia

0

1763

56

3.2

1.00 (reference)

1

7214

408

5.7

1.22 (0.90–1.66)

2

12,419

857

6.9

1.24 (0.91–1.69)

3

12,894

889

6.9

1.15 (0.84–1.58)

4

8314

699

8.4

1.30 (0.94–1.79)

≥ 5

4798

435

9.1

1.31 (0.94–1.83)

Septicemia

0

1763

55

3.1

1.00 (reference)

1

7214

471

6.5

1.92 (1.43–2.58)

2

12,419

950

7.7

2.07 (1.54–2.79)

3

12,894

1071

8.3

2.19 (1.62–2.95)

4

8314

836

10.1

2.53 (1.86–3.44)

≥ 5

4798

556

11.6

2.76 (2.00–3.80)

Urinary tract infection

0

1763

57

3.2

1.00 (reference)

1

7214

500

6.9

1.29 (0.96–1.73)

2

12,419

991

8.0

1.22 (0.90–1.64)

3

12,894

1197

9.3

1.30 (0.96–1.76)

4

8314

825

9.9

1.29 (0.94–1.76)

≥ 5

4798

523

10.9

1.36 (0.98–1.88)

Infectious complications*

0

1763

148

8.4

1.00 (reference)

1

7214

1160

16.1

1.50 (1.24–1.82)

2

12,419

2340

18.8

1.56 (1.29–1.89)

3

12,894

2612

20.3

1.61 (1.32–1.96)

4

8314

1892

22.8

1.73 (1.42–2.12)

≥ 5

4798

1237

25.8

1.93 (1.56–2.38)

Intensive care

0

1763

254

14.4

1.00 (reference)

1

7214

1485

20.6

1.38 (1.18–1.61)

2

12,419

3047

24.5

1.55 (1.32–1.82)

3

12,894

3412

26.5

1.67 (1.42–1.97)

4

8314

2659

32.0

2.15 (1.81–2.55)

≥ 5

4798

1715

35.7

2.55 (2.12–3.06)

30-day in-hospital mortality

0

1763

18

1.0

1.00 (reference)

1

7214

88

1.2

1.08 (0.64–1.85)

2

12,419

241

1.9

1.57 (0.93–2.66)

3

12,894

246

1.9

1.55 (0.90–2.65)

4

8314

195

2.4

1.87 (1.08–3.25)

≥ 5

4798

121

2.5

2.04 (1.14–3.64)

  1. CI confidence interval, OR odds ratio
  2. *Infectious complications included with pneumonia, septicemia, and urinary tract infection
  3. †Adjusted for all covariates listed in Table 1